The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis
Open accessAbstract
Two distinct IL-18 neutralizing strategies, i.e. a rabbit polyclonal anti-mouse IL-18 IgG and a recombinant human IL-18 binding protein (rhIL-18BP), were used to treat collagen-induced-arthritic DBA/1 mice after clinical onset of disease. The therapeutic efficacy of neutralizing endogenous IL-18 was assessed using different pathological parameters of disease progression. The clinical severity in mice undergoing collagen-induced arthritis was significantly reduced after treatment with both IL-18 neutralizing agents compared to placebo treated mice. Attenuation of the disease was associated with reduced cartilage erosion evident on histology. The decreased cartilage degradation was further documented by a significant reduction in the levels of circulating cartilage oligomeric matrix protein (an indicator of cartilage turnover). Both strategies efficiently slowed disease progression, but only anti-IL-18 IgG treatment significantly decreased an established synovitis. Serum levels of IL-6 were significantly reduced with both neutralizing strategies. In vitro, neutralizing IL-18 resulted in a significant inhibition of TNF-alpha, IL-6, and IFN-gamma secretion by macrophages. These results demonstrate that neutralizing endogenous IL-18 is therapeutically efficacious in the murine model of collagen-induced arthritis. IL-18 neutralizing antibody or rhIL-18BP could therefore represent new disease-modifying anti-rheumatic drugs that warrant testing in clinical trials in patients with rheumatoid arthritis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., & Gillespie, M. T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1005 · Cited by 378 · cited 1×
“Pro–IL-18 expression has been detected in antigenpresenting cells such as activated macrophages, Kupffer cells (7), dendritic cells (10), and Langerhans cells (11), as well as articular chondrocytes (12) and osteoblasts (13).”
BackgroundDistinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis
Campbell, I. K., Gerondakis, S., O’Donnell, K., & Wicks, I. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8298 · Cited by 168 · cited 1×
“A similar example has been reported with IL-1 homologues that have high homology to IL-1Ra and have been shown to be antagonists (33) and to block IL-1 (weakly).”
Cited by
Evidence that cytokines play a role in rheumatoid arthritis
Brennan, F. M., & McInnes, I. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36389 · Cited by 1,103
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Therapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases
Akdis, M., Burgler, S., Crameri, R., Eiwegger, T., Fujita, H., Gomez, E., Klunker, S., Meyer, N., O’Mahony, L., Palomares, O., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.050 · Cited by 778
The Role of Cytokines in Cartilage Matrix Degeneration in Osteoarthritis
Goldring, S. R., & Goldring, M. B. (2004) · Clinical Orthopaedics & Related Research · doi:10.1097/01.blo.0000144854.66565.8f · Cited by 654
Synovial fibroblasts: key players in rheumatoid arthritis
Huber, L. C., Distler, O., Tarner, I., Gay, R. E., Gay, S., & Pap, T. (2006) · Rheumatology · doi:10.1093/rheumatology/kel065 · Cited by 607
Gracie, J. A., Robertson, S. E., & McInnes, I. B. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602313 · Cited by 603
Hypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Kim, S.-H., Han, S.-Y., Azam, T., Yoon, D.-Y., & Dinarello, C. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.003 · Cited by 535
Self-citationUrinary interleukin-18 is a marker of human acute tubular necrosis
Parikh, C. R., Jani, A., Melnikov, V. Y., Faubel, S., & Edelstein, C. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.040 · Cited by 522
APC-derived cytokines and T cell polarization in autoimmune inflammation
Gutcher, I., & Becher, B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31720 · Cited by 459
Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process
Dinarello, C. A. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.447s · Cited by 384
Self-citationIhim, S. A., Abubakar, S. D., Zian, Z., Sasaki, T., Saffarioun, M., Maleknia, S., & Azizi, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919973 · Cited by 378
Melnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
IL-18 and Urinary NGAL Predict Dialysis and Graft Recovery after Kidney Transplantation
Hall, I. E., Yarlagadda, S. G., Coca, S. G., Wang, Z., Doshi, M., Devarajan, P., Han, W. K., Marcus, R. J., & Parikh, C. R. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030264 · Cited by 340
IL-32, a proinflammatory cytokine in rheumatoid arthritis
Joosten, L. A. B., Netea, M. G., Kim, S.-H., Yoon, D.-Y., Oppers-Walgreen, B., Radstake, T. R. D., Barrera, P., van de Loo, F. A. J., Dinarello, C. A., & van den Berg, W. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511233103 · Cited by 334
Self-citationMelnikov, V. Y., Faubel, S., Siegmund, B., Lucia, M. S., Ljubanovic, D., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215623 · Cited by 316
NLRP1 Inflammasome Activation Induces Pyroptosis of Hematopoietic Progenitor Cells
Masters, S. L., Gerlic, M., Metcalf, D., Preston, S., Pellegrini, M., O’Donnell, J. A., McArthur, K., Baldwin, T. M., Chevrier, S., Nowell, C. J., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.027 · Cited by 313
The IL-1 cytokine family and its role in inflammation and fibrosis in the lung
Borthwick, L. A. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0559-z · Cited by 294
T cell migration in rheumatoid arthritis
Mellado, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00384 · Cited by 291
Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltagirone, C., & Robinson, R. G. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001879 · Cited by 290
Interleukin‐18 and Host Defense against Infection
Dinarello, C. A., & Fantuzzi, G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374751 · Cited by 287
Self-citationNLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis
Guo, C., Fu, R., Wang, S., Huang, Y., Li, X., Zhou, M., Zhao, J., & Yang, N. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13167 · Cited by 285
Miyoshi, K., Obata, K., Kondo, T., Okamura, H., & Noguchi, K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3512-08.2008 · Cited by 283
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
Self-citationAnti-inflammatory properties of pro-inflammatory interferon-γ
Mühl, H., & Pfeilschifter, J. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00131-0 · Cited by 277
Biomarkers of Acute Kidney Injury
Edelstein, C. L. (2008) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.04.003 · Cited by 272
Interleukin-18 and the Pathogenesis of Inflammatory Diseases
Dinarello, C. A. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.09.013 · Cited by 252
Self-citationDifferences in signaling pathways by IL-1β and IL-18
Lee, J.-K., Kim, S.-H., Lewis, E. C., Azam, T., Reznikov, L. L., & Dinarello, C. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402800101 · Cited by 237
Self-citation
Metadata
- Authors
- Plater-Zyberk, C., Joosten, L. A. B., Helsen, M. M. A., Sattonnet-Roche, P., Siegfried, C., Alouani, S., van de Loo, F. A. J., Graber, P., Aloni, S., Cirillo, R., Lubberts, E., Dinarello, C. A., van den Berg, W. B., & Chvatchko, Y.
- Venue
- Journal of Clinical Investigation
- Published
- 2001-12-15
- Volume
- 108
- Issue
- 12
- Pages
- 1825-1832
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2098496304
- Cited by
- 240
- References
- 2
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.